Antimicrobial resistance (AMR) Summit: Identifying antimicrobial resistance from Sample to Insight

Antimicrobial resistance (AMR) detection and surveillance is a high priority in healthcare and environmental settings for the safety of both patients and the general public. However, working with samples used for this type of monitoring, such as stool or wastewater, can be challenging, from the sample preparation to the sequencing to the bioinformatics.

In this 60-minute online summit, we will take you through a series of biological samples, including stool, wastewater and others. We'll demonstrate the workflows and characteristics of each, together with the answers and insights you can expect. There will also be a live Q&A session, giving you a chance to discuss your questions and use cases with our experts.

At this online virtual AMR summit, you will learn about:

Our kits for nucleic acid extraction from various sample types such as stool, sludge and wastewater
The importance of inhibitor removal during sample preparation
Sequencing workflows for AMR
Benefits of using hybrid capture versus shotgun sequencing
How to generate ShortBRED AMR marker abundance tables
How to associate and compare different metadata, such as sample type (stool, wastewater, etc.)
AMR alpha and beta diversity across sample types and how to determine the depth of coverage

Don't miss this opportunity to learn about our end-to-end antimicrobial solutions for detection and surveillance and get free support from our experts.

Agenda:

Talk 1: Sample preparation – Speaker: Dominic O'Neil, Director, Microbiome Product Development, QIAGEN
Talk 2: Sequencing workflows – Speaker: Dylan Barbera, Global Product Manager, Genomics and UNGS Genotyping, QIAGEN
Talk 3: Bioinformatics analysis and interpretation – Speaker: Daniel Hand, Ph.D., Senior Field Application Scientist, EMEA, QIAGEN Digital Insights

About the speaker

Dominic O'Neil, Director, Microbiome Product Development

QIAGEN

Dominic O'Neil has over 20 years of experience in the biotechnology industry. Before joining QIAGEN, he gained molecular biology expertise at several companies, including three years at the Whitehead/MIT Center for Genome Research in Cambridge, MA, where he participated in completing the initial draft of the human genome. Dominic joined Digene (which later became part of QIAGEN) in 2004 to work on new technology research and development, focusing on sample preparation and diagnostic applications. In 2011, he joined the QIAGEN R&D group in Hilden to work on solutions for next-generation sequencing. Starting in 2015, he focused on microbiome extraction and associated workflows and now leads the R&D group as Director for Microbiome Product Development.

Dylan Barbera, Global Product Manager, UNGS Genotyping

QIAGEN

Dylan Barbera received his bachelor's in biochemistry and molecular biology with a minor in microbiology from Pennsylvania State University. He received his Master's of Science from Mount St. Mary's University in biotechnology and management. Dylan began his career in NGS in 2015 and joined QIAGEN in 2016 as a Quality Control Scientist. He currently serves as Global Product Manager for QIAGEN's microbiology and whole genome sequencing NGS product portfolio.

Daniel Hand, Ph.D., Senior Field Application Scientist, EMEA

QIAGEN Digital Insights

Daniel joined QIAGEN Digital Insights in 2020 as a Senior Field Application Scientist based in the UK, covering primarily the Europe and Middle East regions. He obtained his Ph.D. in molecular microbiology at The University of Birmingham in 2011, studying the canine gut microbiome using metagenomics. He has since worked in the field of infectious disease, applying DNA sequencing technologies to clinical diagnostics, including developing NGS testing, before moving to QIAGEN where he has been supporting customers with their bioinformatics needs across research, industry and clinical fields.